ARMISTICE CAPITAL, LLC - Q1 2017 holdings

$484 Million is the total value of ARMISTICE CAPITAL, LLC's 47 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 85.4% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRput$66,007,000280,000
+100.0%
13.63%
ATRS SellANTARES PHARMA INC$24,708,000
-3.6%
8,700,000
-20.9%
5.10%
-15.9%
VNDA BuyVANDA PHARMACEUTICALS INC$22,512,000
+143.3%
1,608,000
+177.2%
4.65%
+112.5%
WFM NewWHOLE FOODS MKT INCcall$20,804,000700,000
+100.0%
4.30%
NVLNF BuyNOVELION THERAPEUTICS INC$19,890,000
+66.4%
1,852,000
+30.4%
4.11%
+45.2%
FRPT BuyFRESHPET INC$16,236,000
+13.0%
1,476,000
+4.2%
3.35%
-1.4%
REGN NewREGENERON PHARMACEUTICALS$15,500,00040,000
+100.0%
3.20%
HAIN BuyHAIN CELESTIAL GROUP INC$15,178,000
+2.3%
408,000
+7.4%
3.13%
-10.7%
ADMS BuyADAMAS PHARMACEUTICALS INC$15,120,000
+66.9%
864,000
+61.2%
3.12%
+45.7%
HBI BuyHANESBRANDS INC$14,532,000
+25.7%
700,000
+30.6%
3.00%
+9.7%
TPX BuyTEMPUR SEALY INTL INC$13,752,000
+43.9%
296,000
+111.4%
2.84%
+25.6%
KATE BuyKATE SPADE & CO$13,288,000
+255.9%
572,000
+186.0%
2.74%
+210.8%
NOMD BuyNOMAD HLDGS LTD$12,870,000
+49.4%
1,124,000
+24.9%
2.66%
+30.4%
ALXN NewALEXION PHARMACEUTICALS INC$12,851,000106,000
+100.0%
2.65%
RXDX SellIGNYTA INC$12,780,000
+20.6%
1,486,000
-25.7%
2.64%
+5.2%
HZNP BuyHORIZON PHARMA PLC$12,563,000
+19.5%
850,000
+30.8%
2.59%
+4.3%
PII BuyPOLARIS INDS INC$11,062,000
+91.8%
132,000
+88.6%
2.28%
+67.4%
SGYPQ BuySYNERGY PHARMACEUTICALS DEL$10,485,000
+1.3%
2,250,000
+32.4%
2.16%
-11.6%
DECK SellDECKERS OUTDOOR CORP$10,274,000
-17.2%
172,000
-23.2%
2.12%
-27.7%
FTDCQ NewFTD COS INC$10,070,000500,000
+100.0%
2.08%
VSTO NewVISTA OUTDOOR INC$9,266,000450,000
+100.0%
1.91%
AVDL NewAVADEL PHARMACEUTICALS PLCsponsored adr$9,254,000956,000
+100.0%
1.91%
SEAS NewSEAWORLD ENTMT INC$8,770,000480,000
+100.0%
1.81%
ENTA BuyENANTA PHARMACEUTICALS INC$8,378,000
+9.7%
272,000
+19.3%
1.73%
-4.3%
SAM BuyBOSTON BEER INCcl a$7,811,000
+35.3%
54,000
+58.8%
1.61%
+18.1%
SBBP NewSTRONGBRIDGE BIOPHARMA PLC$7,790,0001,640,000
+100.0%
1.61%
LOCO BuyEL POLLO LOCO HLDGS INC$7,768,000
+64.5%
650,000
+69.3%
1.60%
+43.6%
BBY NewBEST BUY INC$7,373,000150,000
+100.0%
1.52%
 PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0$6,745,000
+20.2%
22,760,0000.0%1.39%
+4.9%
AET SellAETNA INC NEW$6,378,000
-19.6%
50,000
-21.9%
1.32%
-29.9%
ALIM BuyALIMERA SCIENCES INC$6,210,000
+79.7%
4,436,000
+38.6%
1.28%
+56.7%
DECK NewDECKERS OUTDOOR CORPcall$5,973,000100,000
+100.0%
1.23%
ANF NewABERCROMBIE & FITCH COcl a$5,369,000450,000
+100.0%
1.11%
ABUS SellARBUTUS BIOPHARMA CORP$5,200,000
+9.4%
1,600,000
-17.5%
1.07%
-4.4%
DKS NewDICKS SPORTING GOODS INC$4,866,000100,000
+100.0%
1.00%
DFRG BuyDEL FRISCOS RESTAURANT GROUP$4,332,000
+127.5%
240,000
+114.3%
0.90%
+98.9%
TLRDQ SellTAILORED BRANDS INC$4,303,000
-43.9%
288,000
-4.0%
0.89%
-51.0%
AVEO NewAVEO PHARMACEUTICALS INC$2,832,0004,800,000
+100.0%
0.58%
WSM NewWILLIAMS SONOMA INC$2,788,00052,000
+100.0%
0.58%
TLRDQ NewTAILORED BRANDS INCcall$2,390,000160,000
+100.0%
0.49%
BLUE SellBLUEBIRD BIO INC$2,182,000
-11.6%
24,000
-40.0%
0.45%
-22.8%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$1,971,000
+6.7%
128,000
+3.2%
0.41%
-6.9%
ARLZ SellARALEZ PHARMACEUTICALS INC$1,498,000
-88.0%
700,000
-75.3%
0.31%
-89.6%
DYNT NewDYNATRONICS CORP$1,425,000500,000
+100.0%
0.29%
ATEC NewALPHATEC HOLDINGS INC$1,264,000542,414
+100.0%
0.26%
PDLI NewPDL BIOPHARMA INC$1,135,000500,000
+100.0%
0.23%
ZFGN NewZAFGEN INC$522,000112,000
+100.0%
0.11%
BLPH ExitBELLEROPHON THERAPEUTICS INC$0-1,000,000
-100.0%
-0.12%
ZSAN ExitZOSANO PHARMA CORP$0-1,200,000
-100.0%
-0.22%
ROKA ExitROKA BIOSCIENCE INC$0-236,000
-100.0%
-0.24%
HSGX ExitHISTOGENICS CORP$0-1,264,000
-100.0%
-0.50%
ExitDUNKIN BRANDS GROUP INCcall$0-60,000
-100.0%
-0.74%
BJRI ExitBJS RESTAURANTS INC$0-88,000
-100.0%
-0.82%
DLTR ExitDOLLAR TREE INC$0-50,000
-100.0%
-0.91%
JCPNQ ExitPENNEY J C INC$0-700,000
-100.0%
-1.38%
SIG ExitSIGNET JEWELERS LIMITED$0-62,000
-100.0%
-1.38%
TSCO ExitTRACTOR SUPPLY CO$0-100,000
-100.0%
-1.79%
SHPG ExitSHIRE PLCsponsored adr$0-46,000
-100.0%
-1.85%
AEO ExitAMERICAN EAGLE OUTFITTERS NE$0-524,000
-100.0%
-1.88%
ACOR ExitACORDA THERAPEUTICS INC$0-428,000
-100.0%
-1.90%
URBN ExitURBAN OUTFITTERS INC$0-300,000
-100.0%
-2.02%
FLML ExitFLAMEL TECHNOLOGIES SAsponsored adr$0-828,000
-100.0%
-2.04%
CPB ExitCAMPBELL SOUP CO$0-158,000
-100.0%
-2.26%
WFM ExitWHOLE FOODS MKT INC$0-312,000
-100.0%
-2.27%
ExitVERIFONE SYS INCcall$0-700,000
-100.0%
-2.94%
LVS ExitLAS VEGAS SANDS CORP$0-236,000
-100.0%
-2.98%
PCRX ExitPACIRA PHARMACEUTICALS INC$0-400,000
-100.0%
-3.06%
ExitSPDR S&P 500 ETF TRput$0-250,000
-100.0%
-13.22%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q1 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings